Inivata announces launch of clinical trial to evaluate impact of InVisionFirst®-Lung liquid biopsy test on time to appropriate treatment in advanced lung cancer

    NEXT STORY
    Clearside Biomedical Announces Multiple Oral Presentations to be Given at the American Society of Retinal Specialists (ASRS) Annual Meeting
    PREV STORY
    Teleflex Announces Second Quarter 2019 Earnings Conference Call Information 
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Gritstone Oncology Announces Pricing of Initial Public Offering

    EMERYVILLE, Calif., Sept. 27, 2018 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq:GRTS) today announced ...

    author_avatar
    NASDAQ Market News

    MDBriefCase Group Announces New Expert Advisors and Transforms its Online Learning Platform

    author_avatar
    NASDAQ Market News

    Selecta Biosciences Announces Second Quarter 2017 Financial Results and Provides Corporate Update

    Positive Data from Ongoing Phase 2 Study of SEL-212 Reported at Clinical Meetings in ...

    author_avatar
    NASDAQ Market News